Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Gene transfer with herpes simplex vectors
R H Lachmann, S Efstathiou
Journal of Virology
|
April 1, 1997
Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system
R H Lachmann, S Efstathiou
Molecular Medicine Today
|
September 26, 1997
The use of herpes simplex virus-based vectors for gene delivery to the nervous system
R H Lachmann, S Efstathiou
Clinical Science (London, England : 1979)
|
May 21, 1999
Use of herpes simplex virus type 1 for transgene expression within the nervous system
R H Lachmann, S Efstathiou
Expert Opinion on Investigational Drugs
|
February 28, 2001
Substrate reduction therapy for glycosphingolipid storage disorders
R H Lachmann, F M Platt
The Journal of General Virology
|
February 17, 2000
Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system
C Smith, R H Lachmann, S Efstathiou
The Journal of General Virology
|
October 1, 1996
A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection
R H Lachmann, C Brown, S Efstathiou
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1996
Recurrent Goodpasture's disease
J B Levy, R H Lachmann, C D Pusey
Anaesthesia
|
October 1, 1993
Rhabdomyolysis and bilateral diaphragmatic palsies following abdominal tamponade
R H Lachmann, R Y Calne, G R Park
The Journal of General Virology
|
June 4, 1999
An analysis of herpes simplex virus gene expression during latency establishment and reactivation
R H Lachmann, M Sadarangani, H R Atkinson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Gene transfer with herpes simplex vectors
R H Lachmann, S Efstathiou
Journal of Virology
|
April 1, 1997
Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system
R H Lachmann, S Efstathiou
Molecular Medicine Today
|
September 26, 1997
The use of herpes simplex virus-based vectors for gene delivery to the nervous system
R H Lachmann, S Efstathiou
Clinical Science (London, England : 1979)
|
May 21, 1999
Use of herpes simplex virus type 1 for transgene expression within the nervous system
R H Lachmann, S Efstathiou
Expert Opinion on Investigational Drugs
|
February 28, 2001
Substrate reduction therapy for glycosphingolipid storage disorders
R H Lachmann, F M Platt
The Journal of General Virology
|
February 17, 2000
Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system
C Smith, R H Lachmann, S Efstathiou
The Journal of General Virology
|
October 1, 1996
A murine RNA polymerase I promoter inserted into the herpes simplex virus type 1 genome is functional during lytic, but not latent, infection
R H Lachmann, C Brown, S Efstathiou
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1996
Recurrent Goodpasture's disease
J B Levy, R H Lachmann, C D Pusey
Anaesthesia
|
October 1, 1993
Rhabdomyolysis and bilateral diaphragmatic palsies following abdominal tamponade
R H Lachmann, R Y Calne, G R Park
The Journal of General Virology
|
June 4, 1999
An analysis of herpes simplex virus gene expression during latency establishment and reactivation
R H Lachmann, M Sadarangani, H R Atkinson, et al.
Page
of 3